Home
Live Updates
Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology : comparemela.com
Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology
$4.8 million funding from Vsquared Ventures, Practica Capital and Metaplanet, bringing total funding to over $8 million New capital will support a worldwide commercial organisation, enabling
Related Keywords
Vilnius ,
Vilniaus Apskritis ,
Lithuania ,
United States ,
Lithuanian ,
Lise Rechsteiner ,
Juozas Nainys ,
Julie Ferguson ,
Atrandi Biosciences ,
Donatas Keras ,
Andy Watson ,
Vsquared Ventures ,
Practica Capital ,
Business Wire ,
Chief Executive Officer ,
General Partner ,
Droplet Genomics ,
Board Chair ,
Atrandi ,
Iosciences ,
Ecures ,
Funding ,
Advances ,
Lobal ,
Ommercialization ,
Text ,
Single ,
Fell ,
Analysis ,
Technology ,
comparemela.com © 2020. All Rights Reserved.